The Global Suprapubic Catheter Market, by Indication (Benign Prostate Hyperplasia, Urinary Incontinence, and Others), by Material (Rubber, Plastic, and Polyvinyl Chloride), by End User (Hospitals, Ambulatory Surgical Centers, Urology Surgical Centers, and Others), and by Region ( North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 11,265.4 million in 2017 and is projected to exhibit a CAGR of 7.3% during the forecast period (2018 - 2026).
Increasing demand for suprapubic catheters, owing to rising prevalence of bladder cancer is expected to be a major factor driving the suprapubic catheter market forecasted value. For instance, according to American Cancer Society, around 80,470 new cases of bladder cancer are expected in the U.S. in 2019. Among these, estimated cases of bladder cancer in men are 61,700 and 18,770 in women.
Browse 34 Market Data Tables and 27 Figures spread through 160 Pages and in-depth TOC on "Suprapubic Catheter Market, by Indication (Benign Prostate Hyperplasia, Urinary Incontinence, and Others), by Material (Rubber, Plastic, and Polyvinyl Chloride), by End User (Hospitals, Ambulatory Surgical Centers, Urology Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026" To know the latest trends and insights related to Suprapubic Catheter Market, click the link below:
Technological advancements in suprapubic catheterizations is a major factor driving growth of the suprapubic catheterization market. For instance, S-Cath System developed by Mediplus ltd. utilizes the Seldinger technique, which is a patented system for suprapubic catheterization that facilitates one tract accurate and precise entry for catheters, decreasing the risks associated with standard blind methods. The Seldinger technique uses a guidewire to place the catheter in the bladder to reduce the risk of bladder or bowel injury. Moreover, the National Institute for Health and Care Excellence (NICE) and the British Association of Urological Surgeons (BAUS) recommended the use of S-Cath System to reduce the risks of conventional products used for SPC. In July 2005, Mediplus received CE marking from European Union for S-Cath system and, in December 2015, Class IIb CE marking for S-Cath System was renewed. Moreover, increasing preference for suprapubic catheters over indwelling catheters, owing to complications associated with indwelling catheters including epididymitis, hematuria, bladder stones, and bladder cancer is expected to boost the suprapubic catheter market size. For instance, in 2018, in a study at Veterans Affairs (VA) Medical Center, 42% of catheterized patients with indwelling catheter were uncomfortable, 48% complained about pain, and 61% of catheterized patients with indwelling catheters experienced restriction in body activities.
Key Takeaways of the Suprapubic Catheter Market: